|
To learn more about Pfizer's My Health Finances, click here.
To learn more about Pfizer Oncology Together, click here.
Handouts & Recording are Now AvailableDetails >
• Incyte Cares
• Janssen CarePath
• Puma Patient Lynx
• Rigel OneCare Details >
• Chronic Care Management Services - CERT Errors
• Disabling Beneficiary Eligibility on the IVR System
• Updated Medicare Hot Links Details >New training opportunities availableDetails >
Recent Oncology Related Articles• Updated Medicare Enrollment Application
• Changes to Claims Processing for Non-Physician Practitioners
• Program Year 2023 Review and Dispute Reminder
• MLN Matters
• And More Details >• 2024 QPP Exception Applications are Available
• Check Initial 2025 MIPS Eligibility
• Opt-In & Voluntary Reporting Options for 2024
• Upcoming MIPS Important Dates and Deadlines Details >• 2024 Measures Under Consideration List Now Available
• NCCI MUE PTP Details >This edition includes articles on• Navigating Reclassification from Inpatient to Outpatient Observation
• Coding Challenge: Understanding Underdosing
• New Settlement Highlights Old Fraud: Upcoding Details >
Recent Oncology Related News• Upcoming Medicine Coverage Changes
• MESSA Offering 5-Tier Prescription Drug Plan
• Step Therapy Requirements Added for Some Medicines
• HEDIS Medical Record Reviews Begin in February
• And More Details >Publications• The Record
• BCN Provider News Details >
Last Reviewed/Updated 12-18-24• Update! Procrit or Epoetin Class Drugs Maintenance
• BCBSM Below Cost Reimbursement
• 0885 Claims Denied
• Procrit Denials (693)
• And More Details >• Changes Coming to Medical Plan Drug Lists
• December 2024 OfficeLink Update Details >• Multifactor Authentication (MFA) Coming Soon
• HEDIS MY 2024 Medical Record Review Project
• Update - HAP CareSource Marketplace Plans
• Reminder - Benefit Policies, Prior Auth, & Pharmacy Information Details >• New Resources Available for the HMA Product, Launching January 1
• Final 2025 PIP Program Manual & Supporting Resources Available
• The Best Way for Practices to Communicate With us is Through Prism
• Credentialing and Enrollment Status Updates are Available in Prism Details >• Medical Policy Updates
• Reimbursement Policy Updates
• Specialty Medical Injectable Drug Program Updates
• Pharmacy and Clinical Updates Details >
• AstraZeneca Imfinzi (durvalumab)
• Jazz Pharmaceutical Ziihera (zanidatamab-hrii) Details > • Geron's RYTELO (imetelstat) Received Permanent J-Code Details >
December 2024 Frequently Asked Questions• Medical Necessity & Secondary Intent
• Calculating the Time for Hourly Increments of Infusion
• Using Code 36415 Details > |
